- Home
- SBT vs NBTX Comparison
SBT vs NBTX Comparison
Compare SBT & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBT
- NBTX
- Stock Information
- Founded
- SBT 1984
- NBTX 2003
- Country
- SBT United States
- NBTX France
- Employees
- SBT N/A
- NBTX N/A
- Industry
- SBT Savings Institutions
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- SBT Finance
- NBTX Health Care
- Exchange
- SBT Nasdaq
- NBTX Nasdaq
- Market Cap
- SBT 243.3M
- NBTX 235.6M
- IPO Year
- SBT 2017
- NBTX 2020
- Fundamental
- Price
- SBT $4.50
- NBTX $5.05
- Analyst Decision
- SBT
- NBTX Strong Buy
- Analyst Count
- SBT 0
- NBTX 2
- Target Price
- SBT N/A
- NBTX $11.50
- AVG Volume (30 Days)
- SBT 59.8K
- NBTX 13.2K
- Earning Date
- SBT 10-23-2024
- NBTX 10-15-2024
- Dividend Yield
- SBT N/A
- NBTX N/A
- EPS Growth
- SBT N/A
- NBTX N/A
- EPS
- SBT 0.13
- NBTX N/A
- Revenue
- SBT $69,973,000.00
- NBTX $45,220,186.00
- Revenue This Year
- SBT N/A
- NBTX N/A
- Revenue Next Year
- SBT $6.68
- NBTX N/A
- P/E Ratio
- SBT $35.03
- NBTX N/A
- Revenue Growth
- SBT N/A
- NBTX 526.17
- 52 Week Low
- SBT $4.40
- NBTX $4.14
- 52 Week High
- SBT $6.01
- NBTX $8.96
- Technical
- Relative Strength Index (RSI)
- SBT 29.40
- NBTX 47.92
- Support Level
- SBT $4.40
- NBTX $4.93
- Resistance Level
- SBT $4.51
- NBTX $5.36
- Average True Range (ATR)
- SBT 0.09
- NBTX 0.36
- MACD
- SBT 0.01
- NBTX -0.00
- Stochastic Oscillator
- SBT 22.73
- NBTX 36.44
About SBT Sterling Bancorp Inc.
Sterling Bancorp Inc is a unitary thrift holding company. Its primary business is the operation of its wholly-owned subsidiary, Sterling Bank, through which it offers a range of loan products to the residential and commercial markets, as well as retail banking services. The products and services offered by the bank include saving and current accounts, demand and term deposits, payment cards, trade finance, fund transfer, treasury and cash management. It provides services such as construction loans, residential real estate, commercial real estate, commercial lines of credit and other consumer loans.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.